AI and blood tests join forces to crack the code of hormone disorders

NCT ID NCT07253454

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will use machine learning and metabolomics (detailed analysis of blood chemicals) to improve diagnosis of hyperandrogenism, a condition causing excess male hormones in women. Researchers will analyze data from 800 women aged 16-45 to better distinguish between common causes like PCOS and rarer genetic conditions. The goal is to create tools that lead to faster, more accurate diagnoses and better management of related health issues like infertility.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to faster, more accurate diagnosis of the cause of hyperandrogenism, helping tailor treatment and reduce infertility.

What could go wrong

This is an observational study using existing data, not a treatment trial. The machine learning models may not prove reliable enough for routine clinical use.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERANDROGENISM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hyperandrogenism

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••